Fundz

Ab Cellera Biologics Inc. reported raising $7.7 Million in an initial SEC Form D filing, from an offering of $7.7 Million

PUBLIC · ABCLAug 10, 2018

Amount Raised

$7.7 Million

$7.7 Million sold, per SEC Form D (first sale Aug 10, 2018)

Round Type

Venture

BiotechnologyHealth CarePharmaceutical

Quick answer

AbCellera raised $7.7 Million in a funding round, dated August 10, 2018.

How much did AbCellera raise?
AbCellera raised $7.7 Million in a funding round on August 10, 2018.
What does AbCellera do?
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
Where is AbCellera based and how big is it?
Fundz records about 610 employees.
Who are the decision-makers at AbCellera?
Fundz holds 2 contacts at AbCellera, including the Infectious Disease. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as AbCellera that raised within 45 days of this round, from Fundz verified event records.

  • VistaGen raised $4.8M on September 21, 2018.
  • valisure llc raised $350K (Seed) on September 6, 2018.
  • Fulcrum Therapeutics raised $80M on September 5, 2018.
  • SciTech Development raised $125K (Pre-Seed) on August 28, 2018.
  • Olema Pharmaceuticals, Inc. raised $6.1M on August 27, 2018.
  • Vivani Medical, Inc. raised $5M on August 17, 2018.

Who to call at AbCellera, and when

A new round usually means AbCellera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AbCellera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AbCellera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AbCellera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AbCellera

About

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AbCellera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsCarl H., Infectious DiseaseSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for AbCellera's next move

See what Strategic adds

AbCellera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.